More people are turning to cannabis for sleep than ever before, and it’s not hard to understand why.
Between demanding work schedules, constant connectivity, and ongoing social, political, and economic stress, quality sleep has become increasingly difficult for many people to maintain. Add in factors like chronic pain, menopause, or aging, and getting consistent rest can become even more challenging. In fact, estimates suggest more than one in three adults don’t get enough sleep on a regular basis.
For years, people have incorporated cannabis into their evening wind-down rituals, often as a way to relax and transition from the pace of the day toward rest. Traditionally, the advice was simple: choose an indica.
That guidance wasn’t necessarily wrong, but it was incomplete.
As cannabis science and lab testing have evolved, researchers and consumers have begun looking beyond strain labels and paying closer attention to the compounds within the plant that shape the overall experience.
At the center of that conversation is CBN (cannabinol).
What Is CBN?
CBN is a naturally occurring cannabinoid found in cannabis and hemp. Unlike THC and CBD, it doesn’t appear in large amounts in freshly harvested flower. Instead, CBN forms gradually as THC is exposed to time, light, and oxygen.
Long before cannabinoids were isolated or labeled, people noticed that older, well-cured cannabis often produced a heavier, more relaxing experience. That effect may partly relate to changes in cannabinoid chemistry as cannabis ages, including the formation of CBN.
Today, modern extraction techniques allow CBN to be isolated and used intentionally, making it possible to create cannabis and hemp products formulated with cannabinoid profiles often associated with nighttime use rather than relying on aged flower or guesswork.
CBN isn’t new. It’s a well-known part of cannabis chemistry that researchers are continuing to study in greater detail.
Why CBN Is Being Studied for Sleep
CBN has drawn growing interest among researchers and consumers exploring cannabinoids associated with nighttime use.
Many people report that products containing CBN feel calming or help them transition into a more restful state. Some users say they fall asleep more easily, stay asleep longer, or wake feeling less groggy compared with other sleep aids. While individual experiences vary, these observations have helped spark renewed interest in studying CBN’s role in sleep.
Unlike THC, CBN is generally not considered intoxicating on its own and does not typically produce the pronounced head-high associated with THC-dominant cannabis. Instead, many users describe its effects as more physically relaxing than mentally stimulating.
Because of this profile, CBN has become a focus of research into cannabinoids that may support nighttime relaxation without the stronger psychoactive effects some people prefer to avoid.
As scientific interest grows, researchers are continuing to investigate how cannabinoids such as CBN interact with the body’s endocannabinoid system and how those interactions may influence sleep-related experiences.
Clinical Evidence: Early Research on CBN and Sleep
Interest in CBN is not limited to anecdotal reports. In 2024, researchers published one of the first double-blind, randomized, placebo-controlled studies examining CBN and sleep quality, titled A Double-Blind, Randomized, Placebo-Controlled Study of the Safety and Effects of CBN With and Without CBD on Sleep Quality.
The study evaluated 20 mg of CBN, both on its own and in combination with CBD, and explored how these formulations influenced sleep-related measures.
Researchers reported that participants receiving CBN experienced improvements in certain sleep-related outcomes, including fewer nighttime awakenings and reduced overall sleep disturbance. Importantly, the study did not find significant increases in next-day fatigue compared with the placebo group.
While the study was relatively small and represents early research in this area, its findings have contributed to growing scientific interest in how cannabinoids such as CBN may influence sleep-related experiences.
Looking Beyond Strain Labels
For some time now, indica strains have been commonly associated with nighttime use, while sativas have often been described as more energizing. Genetics and terpene profiles can still influence how a cultivar feels, but modern cannabinoid testing has added important context.
Cannabis contains more than 100 cannabinoids, along with dozens of terpenes that shape aroma and overall experience. Certain terpenes, such as myrcene and linalool—also found in plants like hops and lavender—are frequently associated with relaxing or calming characteristics.
As researchers and cultivators began examining cannabinoid profiles more closely, some observations suggested that cannabis products described as more sleep-oriented sometimes contained higher levels of CBN. While this relationship is still being studied, it helped shift the conversation away from simple strain labels and toward the broader chemistry of the plant.
In other words, what many people once described as “sleepy indica” effects may reflect a combination of cannabinoid composition, terpene profile, and dosage rather than a single strain category.
How People Use CBN as Part of a Nighttime Routine
Today, CBN is commonly found in products such as CBN gummies and CBN oil, formats that allow consumers to measure servings more consistently.
Gummies are often chosen for convenience and flavor, while oils allow for more flexible serving sizes and appeal to people who prefer sugar-free options or other dietary considerations. These products are often incorporated into evening routines as people wind down at the end of the day.
Some people choose to use CBN on its own, particularly those who prefer to avoid THC or minimize intoxicating effects.
As with other cannabinoids, individual experiences can vary depending on product formulation, cannabinoid ratios, and personal sensitivity.
Where CBD and THC Fit In
While CBN can be effective alone, it’s often paired thoughtfully with other cannabinoids depending on experience level and preference.
For people deciding between cannabinoids for sleep, understanding the differences between CBN vs CBD —and when one may be more effective than the other—can help clarify which approach makes the most sense.
- CBN + CBD is a popular option for people seeking calm, non-intoxicating sleep support. CBD helps quiet stress responses, while CBN has drawn attention for its potential role in sleep-related experiences. Together, the two cannabinoids may work synergistically through the entourage effect, a theory suggesting cannabinoids and terpenes may interact in complex ways within the body.
- For those accustomed to THC, adding a low to moderate dose of THC can deepen the experience. THC adds a euphoric effect, while CBN keeps the overall effect grounded and sleep-oriented.
Products formulated as THC + CBN gummies are designed with this balance in mind, offering a more “dreamy” experience.
The key is moderation. High doses of THC can sometimes increase anxiety or disrupt sleep, especially for sensitive users. Lower, intentional doses paired with CBN tend to produce smoother, more reliable results.
Reading a CBN Lab Report
Any CBN product should come with a third-party lab report. A reliable Certificate of Analysis should clearly list:
- Exact CBN content per serving
- THC, CBD, and any other cannabinoid levels
- Accredited lab testing
- Screens for contaminants
- Recent batch and test dates
When sleep is the goal, precision beats guesswork.
The High Times Takeaway
As more people explore cannabis as part of their nighttime routines, the conversation is shifting from strain names to cannabinoid literacy.
CBN isn’t about getting higher or chasing intensity. It’s about supporting a more intentional wind-down routine: helping some people relax more easily at the end of the day and approach sleep with fewer distractions.
In a culture where quality sleep has become harder for many people to maintain, cannabinoids like CBN are drawing increasing interest from consumers and researchers alike.
Photos courtesy of iStock.
Sponsored Content Disclosure: This article was published as part of a paid commercial arrangement with Rare Cannabinoid Company. It is not independent editorial content. References to cannabinoids, formulations, and consumer use cases reflect the company’s perspective unless otherwise noted, and have not been independently verified by High Times.
